Louisiana proceeds with ‘Netflix’ subscription model to buy hepatitis C drugs – STAT

After months of consideration, Louisiana officials are proceeding with plans for a so-called Netflix payment model for obtaining hepatitis C treatments at an affordable price.
Specifically, the state is seeking drug makers that would be willing to supply treatments in return for subscription-based payments. In essence, the state would agree to pay a fixed amount of money over five years for unlimited access to medication for anyone who is enrolled in the state Medicaid program or incarcerated in a state prison.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What’s included?

Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
Subscriber-only networking events and panel discussions across the country
Monthly subscriber-only live chats with our reporters and experts in the field
Discounted tickets to industry events and early-bird access to industry reports

Ed Silverman

Pharmalot Columnist, Senior Writer
Ed covers the pharmaceutical industry.

LEAVE A REPLY

Please enter your comment!
Please enter your name here